Healthcare stock checkup: Are Redcare Pharmacy & Gerresheimer now a buy after a decline of up to 60.9%?

Redcare Pharmacy and Gerresheimer shares have recently fallen sharply. What are their future prospects? Redcare Pharmacy shares have already lost more than 45 percent of their value since November 2024, even though the company is benefiting from the telemedicine megatrend and the associated cost savings in the healthcare system (June 12, 2025). But what are the reasons? Why Redcare Pharmacy shares have fallen? Redcare Pharmacy (formerly Shop Apotheke Europe) is Europe's leading online pharmacy, already operating in Germany, Austria, France, Belgium, Italy, the Netherlands, and Switzerland. Its offerings include over-the-counter (OTC) products,... Read the full article...

A turning point! 3 uranium stocks before revaluation

At the end of May, US President Donald Trump initiated a far-reaching shift in American energy policy by signing several executive orders. The focus is on the accelerated expansion of nuclear power. A comprehensive package of measures is intended to reform licensing processes, promote smaller reactors, and massively increase the share of nuclear power in the US. This is triggered by the exploding energy demand caused by AI data centers, which makes a stable, low-CO₂ baseload supply absolutely necessary. In our free special report, you will learn which three companies are now at the center of this energy policy realignment and who could particularly benefit from the coming boom in the nuclear industry. Get the latest report! Don't miss out on which stocks are particularly likely to benefit from the energy transition in the US and download the free PDF now.

This exclusive offer is only valid for a limited time! So download it now!